0001209191-23-033841.txt : 20230602 0001209191-23-033841.hdr.sgml : 20230602 20230602164638 ACCESSION NUMBER: 0001209191-23-033841 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230601 FILED AS OF DATE: 20230602 DATE AS OF CHANGE: 20230602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kunz Barbara Lopez CENTRAL INDEX KEY: 0001679970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 23989667 MAIL ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-01 0 0001671584 Aptevo Therapeutics Inc. APVO 0001679970 Kunz Barbara Lopez C/O APTEVO THERAPEUTICS INC. 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 1 0 0 0 0 Common Stock 2023-06-01 4 M 0 297 A 1309 D Restricted Stock Unit 2023-06-01 4 M 0 297 0.00 D Common Stock 297 298 D Restricted Stock Unit 2023-06-02 4 A 0 3571 0.00 A Common Stock 3571 3571 D Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022. The RSUs vest in full on the first anniversary of the date of grant. /s/ SoYoung Kwon, Attorney-in-Fact 2023-06-02